Showing 2321-2330 of 5956 results for "".
- Opthea Announces Executive Leadership Changes and Senior Hireshttps://modernod.com/news/opthea-announces-executive-leadership-changes-and-senior-hires/2482429/Opthea announced several executive leadership changes aimed at bolstering the company’s commercial and clinical expertise as it prepares for the anticipated 2025 topline data readout of phase 3 trials for its lead candidate, sozinibercept, in wet AMD. Daniel Geffken, Co-Founder an
- Oculus Debuts Dual Testing Functionality on Easyfield VR for Enhanced Visual Field Assessmenthttps://modernod.com/news/oculus-debuts-dual-testing-functionality-on-easyfield-vr-for-enhanced-visual-field-assessment/2482416/Oculus has announced the debut of dual testing functionality on its Oculus Easyfield VR, which allows for both Frequency Doubling Perimetry (FDP) and Standard Automated Perimetry (SAP). The integration of Frequency Doubling Perimetry into the Easyfield VR allows for the potent
- Rayner Launches First AI-Designed Spiral IOL, the RayOne Galaxyhttps://modernod.com/news/rayner-announces-launch-of-rayone-galaxy-first-ai-designed-spiral-iol/2482411/Rayner announced its plans to launch the RayOne Galaxy and Galaxy Toric, which the company is calling the world’s first IOL designed with the aid of artificial intelligence. The IOLs will be unveiled at the European Society of Cataract and Refractive Surgeons (
- Ocutech Announces Release of SideSight Ultrasonic Sensor Device for Homonymous Hemianopiahttps://modernod.com/news/ocutech-announces-limited-release-of-sidesight-ultrasonic-sensor-device-for-homonymous-hemianopia/2482405/Ocutech announced the limited first release of its new ultrasonic sensor device, the SideSight. Developed in collaboration with experts in electrical, software, and mechanical engineering, Ocutech says the SideSight is designed to assist individuals who have experienced loss of side vision, a con
- Orbis Launches AI-Led Diabetic Retinopathy Screening Project in Vietnamhttps://modernod.com/news/orbis-launches-ai-led-diabetic-retinopathy-screening-project-in-vietnam/2482401/Orbis has launched an AI-led diabetic retinopathy (DR) project in Vietnam, aiming to screen 72,000 people with diabetes over the next 3 years. The initiative focuses on providing AI-driven screenings, specialized training for screening teams, and enhancing community awareness of diabeti
- Study Examines Effectiveness of Injection of Retinal Progenitor Cells (RPCs) in Treating Photoreceptor Degenerationhttps://modernod.com/news/study-examines-effectiveness-of-injection-of-retinal-progenitor-cells-rpcs-in-treating-photoreceptor-degeneration/2482387/A preclinical study demonstrates the effectiveness of intravitreal injection of retinal progenitor cells (RPCs) (jCell) in treating photoreceptor degeneration. The research, from the Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center at the University of
- First Beyeonics One Augmented Reality Surgical Microscope Installed at Deep Blue Retinahttps://modernod.com/news/first-beyeonics-one-augmented-reality-surgical-microscope-installed-at-deep-blue-retina/2482377/The first Beyeonics One surgical microscope for retinal surgery was installed at Southaven, Mississippi-based Deep Blue Retina. The system will be installed at Desoto Surgery Center, part of the Surgery Partners network. The Beyeonics One system offers precision and
- Nicox Announces Recruitment of Last Patient in US in Denali Phase 3 Trial of NCX 470https://modernod.com/news/nicox-announces-recruitment-of-last-patient-in-us-in-denali-phase-3-trial-of-ncx-470/2482375/Nicox announced the recruitment and randomization of the last patient in the United States in its Denali phase 3 trial of NCX 470. The Denali trial is evaluating NCX 470 safety and efficacy in patients with open-angle glaucoma or ocular hypertension. Ac
- Spryte Medical Receives Breakthrough Device Designation from FDA for Neuro OCT Technologyhttps://modernod.com/news/spryte-medical-receives-breakthrough-device-designation-from-fda-for-neuro-optical-coherence-tomography-noct-technology/2482373/Spryte Medical announced that its neuro Optical Coherence Tomography (nOCT) technology has been granted Breakthrough Device Designation by the FDA. This recognition underscores the potential of nOCT in neurointervention and cerebrovascular treatment. The FDA’s
- Osheru Secures $4.7 Million Seed Funding to Advance Ziplyft Device for Blepharoplasty Surgeryhttps://modernod.com/news/osheru-secures-47-million-seed-funding-to-advance-ziplyft-device-for-blepharoplasty-surgery/2482370/Osheru announced the completion of a $4.7 million funding round to accelerate the development and commercialization of its Ziplyft device for blepharoplasty surgery. Blepharoplasty, a procedure aimed at rejuvenating the appearance of the eyelids, remains one of the most sought-afte